Log In
Print this Print this

evacetrapib (LY2484595)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionCholesteryl ester transfer protein (CETP) inhibitor
Molecular Target Cholesteryl ester transfer protein (CETP)
Mechanism of ActionCholesteryl ester transfer protein (CETP) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationDyslipidemia
Indication DetailsTreat patients with elevated LDL-C or low HDL-C
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today